Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists SOUTH SAN FRANCISCO, Calif., April 10 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS), a …
:rolleyes: 3,18 - 3,68 hab schon schlechtere Einstände gehabt. ;)